{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_18300", "batch_size": 260, "batch_pos": 57, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 2, "answer": "no", "rationale": "The segment reports factual discussions without high-potency language.", "method": "llm_batch", "batch_id": "batch_2_14560", "batch_size": 260, "batch_pos": 40, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 3, "answer": "no", "rationale": "Factual statement without moderate verb + scale/impact.", "method": "llm_batch", "batch_id": "batch_3_16328", "batch_size": 260, "batch_pos": 249, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_16436", "batch_size": 260, "batch_pos": 234, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 5, "answer": "no", "rationale": "The segment reports discussions with government, which is factual information.", "method": "llm_batch", "batch_id": "batch_5_6580", "batch_size": 260, "batch_pos": 232, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 6, "answer": "no", "rationale": "The segment describes preparedness (Q5 Capability) but not the Q6 pattern.", "method": "llm_batch", "batch_id": "batch_6_1544", "batch_size": 260, "batch_pos": 203, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 7, "answer": "no", "rationale": "No bare negation detected.", "method": "llm_batch", "batch_id": "batch_7_17832", "batch_size": 260, "batch_pos": 189, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 8, "answer": "yes", "rationale": "Describes an action/capability ('are in discussions', 'advancing our pandemic flu candidate') without active reassurance (Guard 2 applies).", "method": "llm_batch", "batch_id": "batch_8_16084", "batch_size": 260, "batch_pos": 39, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
